ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ The 11th SFR Symposium : 2019-07-12±³À°ÀÏÀÚ : 2019-07-12
±³À°Àå¼Ò : ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø º»°ü 5Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
The 11th SFR SymposiumÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
´ã´çÀÚ : Á¤ÀºÇý
¿¬¶ôó : 02-582-8212
À̸ÞÀÏ :
grace@kscvi.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 4 ½Ã°£ 12ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í -Àü¹®ÀÇ/°³¿øÀÇ/ÀϹÝÀÇ: 60,000 -ÀüÀÓÀÇ/Àü°øÀÇ: 30,000 -°£È£»ç/ÀÇ·á±â»ç/ÀÇ´ë»ý/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/ÀÓ»óº´¸®»ç/Àǹ«±â·Ï»ç: 20,000 -»ê¾÷ü/±âŸ: 120,000 * ÇöÀåµî·Ï¸¸ °¡´ÉÇÕ´Ï´Ù
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-12 ´ë°´ç 13:30~13:41 How to Treat Type 1 & 2 ISR Lesions after Long Stent Implantation Á¶À±°æ(°è¸íÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 13:41~13:52 What You Need to Know before rePCI for Type 3 & 4 ISR Lesions ÀÌÀåÈÆ(°æºÏÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 13:52~14:03 How to Treat for LM Bifurcation ISR Lesions after Simple Stenting ÇÏ»óÁø(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 14:03~14:14 Do You Believe the Role of FFR for ISR Lesions? ±èÇö±¹(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 14:14~14:25 Different Roles of Image Evaluation in ISR Lesions: IVUS vs. OCT È«¿µÁØ(Àü³²ÀÇ´ë)
Åä·Ð 07-12 ´ë°´ç 14:25~14:30 Discussion ()
±³À°½Ã°£ 07-12 ´ë°´ç 14:30~14:41 Prevention & Management of TEVAR Complication/Failure ÀÌÇÑö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 14:41~14:52 Prevention & Management of EVAR Complication/Failure õ¹Î±¸(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 14:52~15:03 Prevention & Management of Aortiliac Intervention Complication/Failure ½Å»óÈÆ(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 15:03~15:14 Prevention & Management of FP Intervention Complication/Failure À̽Âȯ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 15:14~15:25 Prevention & Management of BTK Intervention Complication/Failure ÃÖÀÍÁØ(°¡Å縯ÀÇ´ë)
Åä·Ð 07-12 ´ë°´ç 15:25~15:30 Discussion ()
ÈÞ½Ä 07-12 15:30~15:50 Coffee Break ()
±³À°½Ã°£ 07-12 ´ë°´ç 15:50~16:01 Does It Really Matter in Stent Failure?: Strut Coverage, Acute Malapposition, etc ÀÌ»ó¿±(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 16:01~16:12 Role of Post-stent FFR in Prediction of Stent Failure µµÁØÇü(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 16:12~16:23 Different Stent Design, Polymer, and Strut Thickness Make Different Acute and Chronic Outcomes ¹Ú°æÀÏ(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 16:23~16:34 Future Direction of Newer Stents to Prevent Stent Failure ±è¼öÁß(°æÈñÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 16:34~16:45 Medical Therapy to Prevent Stent Failure: Antiplatelet Therapy and Others Á¤¿µÈÆ(°æ»óÀÇ´ë)
Åä·Ð 07-12 ´ë°´ç 16:45~16:50 Discussion ()
±³À°½Ã°£ 07-12 ´ë°´ç 16:50~17:02 Rotablation for Stent Underexpansion ±èµ¿±â(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 17:02~17:14 We Need "Graft Stent" ¹ÚÇÏ¿í(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 17:14~17:26 What Is the Best Strategy for the Treatment of Calcified Left Main Bifurcation Lesion? ÀÌÁßÈñ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 17:26~17:38 Endless Treatment of Severe Vascular Disease Patient ÀÌöÇö(°è¸íÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 17:38~17:50 In-Stent CTO, Not as Easy as It Looks Àü±¹Áø(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 07-12 ´ë°´ç 17:50~18:02 Treatment Strategy of Totally IVUS and FFR Guided Recurrent LAD Stent Failure Ȳº´Èñ(°¡Å縯ÀÇ´ë)